期刊文献+

早期应用小剂量多巴胺联合呋塞米治疗心力衰竭的疗效研究 被引量:14

Curative effect observation of early application small doses of dopamine combined with furosemide in the treatment of cardiac failure
下载PDF
导出
摘要 目的研究与探讨早期应用小剂量多巴胺联合呋塞米治疗心力衰竭的疗效。方法将来本院治疗的116例心力衰竭患者随机分为对照组和观察组,对照组58例采用常规方法治疗,观察组58例在对照组治疗基础上加用小剂量多巴胺联合呋塞米治疗,比较两组患者的治疗效果。结果对照组总有效率为79.31%,观察组总有效率为91.38%,观察组疗效优于对照组,两组患者治疗效果及心功能改善情况差异有统计学意义(P<0.05)。结论早期应用小剂量多巴胺联合呋塞米治疗心力衰竭,疗效显著,值得临床予以推广。 Objective To research and discuss the curative effect of early application small doses of dopamine combined with furosemide in the treatment of cardiac failure. Methods One hundred and sixteen cases of patients with cardiac failure treated in our hospital were selected and randomly divided into the observation group and the control group, 58 cases in the control group were given conventional therapy, 58 cases in the observation group were given small doses of dopamine combined with furosemide therapy on the basis of the control group. The therapeutic effect between the two groups was compared. Results The total effective rate of the control group was 79.31%, which was 91.38% of the observation group, the curative effect of the observation group was better than that of the control group, and there were significant difference in therapeutic effect and the improvement of heart failure between two groups (P 0.05). Conclusion The curative effect of early application small doses of dopamine combined with furosemide in the treatment of cardiac failure is significant, which is worthy of clinical application.
出处 《中国当代医药》 2012年第26期76-77,共2页 China Modern Medicine
关键词 心力衰竭 多巴胺 呋塞米 疗效研究 Cardiac failure Dopamine Furosemide Curative effect observation
  • 相关文献

二级参考文献19

  • 1陈东成,黎妙嫦,沈泽贤,杨敏怡.参麦注射液联用多巴胺、硝普钠治疗难治性心力衰竭的疗效评价[J].中西医结合心脑血管病杂志,2005,3(10):849-850. 被引量:6
  • 2杨帆,赖沙毅.充血性心力衰竭患者利尿剂抵抗[J].医学综述,2006,12(16):999-1000. 被引量:16
  • 3张萍.6分钟步行试验[J].临床心电学杂志,2007,16(3):236-237. 被引量:56
  • 4Adams KF,Mathur VS,Gheorghiade M,et al.B-type natriuretic peptide:From bench to bedside[J].American Heart Journal,2003,145 (2):534-546.
  • 5Bettencourt PM.Clinical usefulness of B-type natriuretic peptide measurement:present and future perspectives[J].Heart,2005,91(11):1489-1494.
  • 6Hartmann F,Packer M,Coats AJ,et al.Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure:A substudy of the carvedilol prospective randomized cumulative survival(COPERNICUS) Trial[J].Circulation,2004,110(13):1780-1786.
  • 7Bettencourt P,Azevedo A,Pimenta J,et al.N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients[J].Circulation,2004,110(15):2168-2174.
  • 8Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society o Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29: 2388- 2442.
  • 9Kramer BK,Schweda F,Riegger GA.Diuretic treatment and diuretic resistance in heart failure[J].Am J Med,1999,106(1):90-96.
  • 10Neuberg GM,Miller AB,O′Connor CM,et al.Diuretic resistace predicts mortality in patients with advanced ranced heart failure[J].Am Heart J,2002,14(1):31-38.

同被引文献73

引证文献14

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部